PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
04-Jun-2024 Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels AccessWire
04-Jun-2024 The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect AccessWire
04-Jun-2024 Amphastar Announces Additional $50 Million Increase to its Share Buyback Program AccessWire
04-Jun-2024 Data4Cure to Present at the BIO International Convention 2024 AccessWire
03-Jun-2024 Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors AccessWire
03-Jun-2024 KindlyMD Announces Closing of $6.8 Million Initial Public Offering AccessWire
03-Jun-2024 MedTech Outlook 2024 for Latin America Released AccessWire
03-Jun-2024 PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation AccessWire
03-Jun-2024 Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology AccessWire
03-Jun-2024 TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) AccessWire
03-Jun-2024 Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024 AccessWire
03-Jun-2024 CNS Pharmaceuticals Announces Reverse Stock Split AccessWire
03-Jun-2024 Aptevo Participating in the BIO International Convention AccessWire
03-Jun-2024 Modular Medical Announces Addition to the Russell Microcap(R) Index AccessWire
03-Jun-2024 Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection AccessWire
03-Jun-2024 Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year AccessWire
03-Jun-2024 Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference AccessWire
31-May-2024 Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference AccessWire
31-May-2024 KindlyMD Announces Pricing of $6.8 Million Initial Public Offering AccessWire
31-May-2024 Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) AccessWire